Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAU 2017 | What is the best second-line treatment of advanced renal cell carcinoma (RCC)?

Axel Merseburger • 26 Mar 2017
EAU 2017
Kidney Cancer Axitinib Cabozantinib Imatinib Nivolumab

Axel Merseburger, from the Schleswig-Holstein University Hospital, Lübeck, Germany, discusses the joint meeting of the EAU and Japanese Urological Association at the European Association of Urology (EAU) conference 2017 in London, UK. European and Japanes uro-oncologists discussed the best second-line treatment in advance metastatic renal cell carcinoma (RCC).

More from Axel Merseburger

1:23
The evolving treatment landscape of mHSPC and mCRPC
Axel Merseburger • 17 Feb 2022
1:14
Discovering novel biomarkers in prostate cancer
Axel Merseburger • 17 Feb 2022
1:10
PRESIDE: investigating continued treatment with enzalutamide in PC following disease progression
Axel Merseburger • 17 Feb 2022
1:37
The impact of COVID-19 on the care of patients with metastatic GU cancers
Axel Merseburger • 17 Feb 2022

Related Videos

2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:52
LITESPARK-004: ESA use in VHL disease-associated RCC
Benjamin Maughan • 26 Jan 2024
3:04
Evaluating the role of radiotherapy in primary and metastatic RCC
Sophia Kamran • 26 Jan 2024
2:14
Managing renal cell carcinoma after progressing on checkpoint inhibitors
David Braun • 14 Feb 2024
The content of VJOncology is intended for healthcare professionals